Journal of Korean Medical Science · 2003 · 43 citations · 14 references
MedicineGeneticsMolecular GeneticsCancer GeneticsGastrointestinal OncologyMolecular OncologyCancer GenomicsCancer Molecular PathologyCancer RiskGastric CancerGenetic Risk AssessmentMolecular Risk FactorsCancer Risk AssociationDiffuse-type Gastric CancerGastric Cancer GeneticsIntestinal-type Gastric CancerMolecular Risk MarkersRestriction Fragment Length Polymorphism AnalysisSingle-nucleotide Polymorphism AnalysisSingle-nucleotide Polymorphism Variation
Recently, the -160 C/A polymorphism, located within the regulatory region of Ecadherin promoter, has been shown to influence E-cadherin transcription by altering transcription factor binding. We examined the effect of this polymorphism on risk of gastric cancer and on histological classification of intestinal- and diffuse-type gastric cancer in 146 normal healthy individuals and 292 Korean gastric cancer patients. Genomic DNA samples were examined by polymerase chain reaction (PCR)-single strand conformational polymorphism (SSCP)-sequencing and confirmed by restriction fragment length polymorphism (RFLP). Unexpectedly, there was no significant difference in the genotype frequencies of the polymorphism between normal control and gastric cancer patients (x(2) test, p=0.433). The estimated odd ratio of C/C to A/A genotype in gastric cancer cases was 1.07 (95% confidence interval, 0.396-2.870). We also found no evidence for differences in risk for the intestinal- and diffuse-type gastric cancer. These results suggest that the -160 C/A polymorphism of the E-cadherin has no direct effect on the risk of Korean gastric cancer development and on its histological classification.
14
E-cadherin germline mutations in familial gastric cancer
Parry Guilford, Justin Hopkins, James Harraway et al. · Nature · 1998 · 1.7K citations
A causal role for E-cadherin in the transition from adenoma to carcinoma
Anne‐Karina T. Perl, Petra Wilgenbus, Ulf Dahl et al. · Nature · 1998 · 1.4K citations